Evidence map›Paper›PMID 31533821›Full record

ArticleMalaria journal2019

Plasmodium vivax cerebral malaria in an adult patient in Sudan.

Maowia M Mukhtar, Omer A Eisawi, Seth A Amanfo, Elwaleed M Elamin, Zeinab S Imam, Faiza M Osman, Manasik E Hamed

Open access · goldAbstract readCase Reports
In one paragraph

Article in Malaria journal, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.4field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Maowia M MukhtarBioscience Research Institute, Ibn Sina University, P.O. Box 11463, Khartoum, Sudan. mmukhtar@tropmedicine.org.
Omer A EisawiDepartment of Medicine, Aliaa' Specialized Hospital, Khartoum, Sudan.
Seth A AmanfoNIHR Global Health Research Unit Tackling Infections to Benefit Africa at the University of Edinburgh, Usher Institute, University of Edinburgh, Edinburgh, UK.
Elwaleed M ElaminBioscience Research Institute, Ibn Sina University, P.O. Box 11463, Khartoum, Sudan.
Zeinab S ImamBioscience Research Institute, Ibn Sina University, P.O. Box 11463, Khartoum, Sudan.
Faiza M OsmanInstitute of Endemic Diseases, University of Khartoum, Khartoum, Sudan.
Manasik E HamedBioscience Research Institute, Ibn Sina University, P.O. Box 11463, Khartoum, Sudan.
University of Khartoum · SDUniversity of Edinburgh · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPlasmodium vivax infection is rising in sub-Saharan Africa, where Plasmodium falciparum is responsible for more than 90% of malaria cases. While P. vivax is identified as a major cause of severe and cerebral malaria in South east Asia, the Pacific and South America, most of the severe and cerebral cases in Africa were attributed to P. falciparum. Cases of severe malaria due to P. vivax are emerging in Africa. A few severe P. vivax cases were reported in Eastern Sudan and they were underestimated due to the lack of accurate diagnosis, low parasitaemia and seldom use of rapid diagnostic tests (RDTs). CASE PRESENTATION: A 60-year-old Sudanese male presented to the Al Kuwaiti hospital in the Sudan capital Khartoum. On admission, the patient was complaining of fever (measured temperature was 38 °C), sweating, chills, vomiting and confusion in the past 2 days prior to his admission. He rapidly deteriorated into a coma state within 48 h of the admission, with significant neck stiffness. He was admitted to the intensive care unit and was suspected of meningitis. Lumbar puncture was not performed since the patient was suffering from spinal cord disc. Brain CT scan was unremarkable. Several biochemical, haematological tests, and blood film for malaria were performed. The results of the laboratory tests were within the normal range except of mild elevation of the total white blood cell count and a significant decrease in the platelets count. Malaria parasites were seen in the blood film with high parasitaemia (quantified as 3 +++). The patient was diagnosed as P. vivax cerebral malaria based on the positive blood film and the amplification of P. vivax specific 499 bp amplicon using Plasmodium multi-species multiplex Polymerase Chain Reaction (PCR). The patient was treated with quinine 10 mg/kg body weight for 10 days followed by primaquine 15 mg/days PO for 2 weeks. The symptoms subsided within 48 h and the patients was cured and released from the hospital.

conclusionsPlasmodium vivax is an emerging cause of cerebral malaria in adults in Sudan and should be considered in the differential diagnosis of cerebral malaria for proper management of patients.

Indexed as

HumansMalaria, CerebralMalaria, VivaxMaleMiddle AgedPlasmodium vivaxSudanTreatment OutcomeCerebral malariaPlasmodium vivaxSudan

Identifiers

PMID31533821
PMCPMC6751804
OpenAlexW2974208868

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.